203 related articles for article (PubMed ID: 23178582)
41. Sonic Hedgehog-Activated Large Cell/Anaplastic Medulloblastoma with Myogenic Differentiation.
Rao S; Uppar AM; Santosh V
World Neurosurg; 2020 Mar; 135():16-18. PubMed ID: 31809895
[TBL] [Abstract][Full Text] [Related]
42. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.
Swartling FJ; Savov V; Persson AI; Chen J; Hackett CS; Northcott PA; Grimmer MR; Lau J; Chesler L; Perry A; Phillips JJ; Taylor MD; Weiss WA
Cancer Cell; 2012 May; 21(5):601-613. PubMed ID: 22624711
[TBL] [Abstract][Full Text] [Related]
43. New molecular targets for the treatment of medulloblastoma.
Ramey W; Kalani MY
World Neurosurg; 2013; 80(1-2):6-7. PubMed ID: 23689126
[No Abstract] [Full Text] [Related]
44. REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma.
Di Marcotullio L; Ferretti E; De Smaele E; Argenti B; Mincione C; Zazzeroni F; Gallo R; Masuelli L; Napolitano M; Maroder M; Modesti A; Giangaspero F; Screpanti I; Alesse E; Gulino A
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10833-8. PubMed ID: 15249678
[TBL] [Abstract][Full Text] [Related]
45. An embryonic origin for medulloblastoma.
Valtz NL; Hayes TE; Norregaard T; Liu SM; McKay RD
New Biol; 1991 Apr; 3(4):364-71. PubMed ID: 2065021
[TBL] [Abstract][Full Text] [Related]
46. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
47. Targeting mTOR as a Therapeutic Approach in Medulloblastoma.
Aldaregia J; Odriozola A; Matheu A; Garcia I
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932116
[TBL] [Abstract][Full Text] [Related]
48. Epithelial differentiation in medulloblastoma: comparison with other embryonal tumors of neuroectodermal origin.
Sugita Y; Tokunaga O; Terasaki M; Morimatsu M; Shigemori M
Pathol Int; 2003 Dec; 53(12):858-64. PubMed ID: 14629752
[TBL] [Abstract][Full Text] [Related]
49. Review: personalized mice: modelling the molecular heterogeneity of medulloblastoma.
Markant SL; Wechsler-Reya RJ
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):228-40. PubMed ID: 22070547
[TBL] [Abstract][Full Text] [Related]
50. Modeling medulloblastoma with genetically engineered mice.
Fults DW
Neurosurg Focus; 2005 Nov; 19(5):E7. PubMed ID: 16398471
[TBL] [Abstract][Full Text] [Related]
51. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
[TBL] [Abstract][Full Text] [Related]
52. N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma.
Browd SR; Kenney AM; Gottfried ON; Yoon JW; Walterhouse D; Pedone CA; Fults DW
Cancer Res; 2006 Mar; 66(5):2666-72. PubMed ID: 16510586
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma.
Venkataraman S; Birks DK; Balakrishnan I; Alimova I; Harris PS; Patel PR; Handler MH; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
J Biol Chem; 2013 Jan; 288(3):1918-28. PubMed ID: 23212916
[TBL] [Abstract][Full Text] [Related]
54. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.
Aref D; Moffatt CJ; Agnihotri S; Ramaswamy V; Dubuc AM; Northcott PA; Taylor MD; Perry A; Olson JM; Eberhart CG; Croul SE
Brain Pathol; 2013 Mar; 23(2):178-91. PubMed ID: 22966790
[TBL] [Abstract][Full Text] [Related]
55. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
56. Neonatal cerebellar medulloblastoma originating from the fetal external granular layer.
Kadin ME; Rubinstein LJ; Nelson JS
J Neuropathol Exp Neurol; 1970 Oct; 29(4):583-600. PubMed ID: 5471923
[No Abstract] [Full Text] [Related]
57. Hedgehog-mediated regulation of PPARγ controls metabolic patterns in neural precursors and shh-driven medulloblastoma.
Bhatia B; Potts CR; Guldal C; Choi S; Korshunov A; Pfister S; Kenney AM; Nahlé ZA
Acta Neuropathol; 2012 Apr; 123(4):587-600. PubMed ID: 22407012
[TBL] [Abstract][Full Text] [Related]
58. Development and cancer of the cerebellum.
Hatten ME; Roussel MF
Trends Neurosci; 2011 Mar; 34(3):134-42. PubMed ID: 21315459
[TBL] [Abstract][Full Text] [Related]
59. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
Paul MR; Zage PE
Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
[No Abstract] [Full Text] [Related]
60. Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis.
Di Marcotullio L; Ferretti E; De Smaele E; Screpanti I; Gulino A
Mol Neurobiol; 2006 Dec; 34(3):193-204. PubMed ID: 17308352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
